Ratings
0
Nobody has rated this yet. Be the first!
Works
2
FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell models
Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer
